Nephron‐sparing surgery
2007; Wiley; Volume: 99; Issue: 5b Linguagem: Inglês
10.1111/j.1464-410x.2007.06831.x
ISSN1464-410X
AutoresBrian R. Lane, Andrew C. Novick,
Tópico(s)Renal and related cancers
ResumoBJU InternationalVolume 99, Issue 5b p. 1245-1250 Nephron-sparing surgery Brian R. Lane, Brian R. Lane Glickman Urological Institute, Cleveland Clinic, Cleveland, OH, USASearch for more papers by this authorAndrew C. Novick, Andrew C. Novick Glickman Urological Institute, Cleveland Clinic, Cleveland, OH, USASearch for more papers by this author Brian R. Lane, Brian R. Lane Glickman Urological Institute, Cleveland Clinic, Cleveland, OH, USASearch for more papers by this authorAndrew C. Novick, Andrew C. Novick Glickman Urological Institute, Cleveland Clinic, Cleveland, OH, USASearch for more papers by this author First published: 13 April 2007 https://doi.org/10.1111/j.1464-410X.2007.06831.xCitations: 38 Andrew C. Novick, Glickman Urological Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A100, Cleveland, Ohio 44195, USA.e-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106–30 2 Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281: 1628–31 3 Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Urology 2004; 64: 462–7 4 Lang H, Lindner V, Martin M et al. Prognostic value of multifocality on progression and survival in localized renal cell carcinoma. Eur Urol 2004; 45: 749–53 5 Richstone L, Scherr DS, Reuter VR et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol 2004; 171: 615–20 6 Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005; 353: 2477–90 7 Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297–301 8 Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev 2005; 1: CD001425 9 Lane BR, Rini BI, Novick AC, Campbell SC. Targeted molecular therapy for renal cell carcinoma. Urology 2007; 69: 3–10 10 Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170: 2217–20 11 Patard JJ, Dorey FJ, Cindolo L et al. Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol 2004; 172: 2167–71 12 Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 2006; 67: 254–9 13 Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol 1999; 161: 33–5 14 Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000; 163: 442–5 15 Fergany AF, Saad IR, Woo L, Novick AC. Open partial nephrectomy for tumor in a solitary kidney: experience with 400 cases. J Urol 2006; 175: 1630–3 16 Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol 2006; 175: 2027–31 17 Lerner SE, Hawkins CA, Blute ML et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996; 155: 1868–73 18 D'Armiento M, Damiano R, Feleppa B, Perdona S, Oriani G, De Sio M. Elective conservative surgery for renal carcinoma versus radical nephrectomy: a prospective study. Br J Urol 1997; 79: 15–9 19 Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 2000; 163: 730–6 20 Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000; 75: 1236–42 21 Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999; 162: 1930–3 22 Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 2004; 171: 1066–70 23 Patard JJ, Shvarts O, Lam JS et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004; 171: 2181–5 24 Becker F, Siemer S, Hack M, Humke U, Ziegler M, Stockle M. Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm. Eur Urol 2006; 49: 1058–64 25 Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, Benson MC, McKiernan JM. Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 2006; 67: 260–4 26 Campbell SC, Novick AC. Expanding the indications for elective partial nephrectomy: is this advisable? Eur Urol 2006; 49: 952–4 27 Castilla EA, Liou LS, Abrahams NA et al. Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma. Urology 2002; 60: 993–7 28 Steinbach F, Stockle M, Hohenfellner R. Clinical experience with nephron-sparing surgery in the presence of a normal contralateral kidney. Semin Urol Oncol 1995; 13: 288–91 29 Barbalias GA, Liatsikos EN, Tsintavis A, Nikiforidis G. Adenocarcinoma of the kidney: nephron-sparing surgical approach vs radical nephrectomy. J Surg Oncol 1999; 72: 156–61 30 Belldegrun A, Tsui KH, DeKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 Tumor-Node-Metastasis staging system. J Clin Oncol 1999; 17: 2868–75 31 Sorbellini M, Kattan MW, Snyder ME, Hakimi AA, Sarasohn DM, Russo P. Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. J Urol 2006; 176: 472–6 32 Gill IS, Desai MM, Kaouk JH et al. Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J Urol 2002; 167: 469–7 33 Gill IS, Ramani AP, Spaliviero M et al. Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant. Urology 2005; 65: 463–6 34 Frank I, Colombo JR Jr, Rubinstein M, Desai M, Kaouk J, Gill IS. Laparoscopic partial nephrectomy for centrally located renal tumors. J Urol 2006; 175: 849–52 35 Gill IS, Colombo JR Jr, Frank I, Moinzadeh A, Kaouk J, Desai M. Laparoscopic partial nephrectomy for hilar tumors. J Urol 2005; 174: 850–4 36 Gill IS, Colombo JR Jr, Moinzadeh A et al. Laparoscopic partial nephrectomy in solitary kidney. J Urol 2006; 175: 454–8 37 Lane BR, Gill IS. 5-year outcomes of laparoscopic partial nephrectomy. J Urol 2007; 177: 70–4 38 Allaf ME, Bhayani SB, Rogers C et al. Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome. J Urol 2004; 172: 871–3 39 Abukora F, Nambirajan T, Albqami N et al. Laparoscopic nephron sparing surgery: evolution in a decade. Eur Urol 2005; 47: 488–93 40 Seifman BD, Hollenbeck BK, Wolf JS Jr. Laparoscopic nephron-sparing surgery for a renal mass: 1-year minimum follow-up. J Endourol 2004; 18: 783–6 41 Jeschke K, Peschel R, Wakonig J, Schellander L, Bartsch G, Henning K. Laparoscopic nephron-sparing surgery for renal tumors. Urology 2001; 58: 688–92 42 Link RE, Bhayani SB, Allaf ME et al. Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol 2005; 173: 1690–4 43 Aron M, Gill IS. Renal tumor ablation. Curr Opin Urol 2005; 15: 298–305 44 Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 2006; 68 (Suppl.): 7–13 45 Schwartz BF, Rewcastle JC, Powell T, Whelan C, Manny T Jr, Vestal JC. Cryoablation of small peripheral renal masses: a retrospective analysis. Urology 2006; 68 (Suppl.): 14–8 46 Cestari A, Guazzoni G, Dell'Acqua V et al. Laparoscopic cryoablation of solid renal masses: intermediate term followup. J Urol 2004; 172: 1267–70 47 Permpongkosol S, Link RE, Solomon SB, Kavoussi LR. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings. J Urol 2006; 176: 463–7 48 McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 2005; 174: 61–3 49 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226: 417–24 50 Varkarakis IM, Allaf ME, Inagaki T et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol 2005; 174: 456–60 Citing Literature Volume99, Issue5bMay 2007Pages 1245-1250 ReferencesRelatedInformation
Referência(s)